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Abstract The solution structure of the recombinant ick anticoagulant protein (rTAP) was determined by ‘H nuclear magnetic resonance (NMR) 
spectroscopy in aqueous olution at pH 3.6 and 36°C. rTAP is a 60-residue protein functioning as a highly specific inhibitor of the coagulation protease 
factor Xa, which was originally isolated from the tick Ornithodoros moubata. Its regular secondary structure consists of a two-stranded antiparallel 
p-sheet with residues 22-28 and 32-38, and an a-helix with residues 51-60. The relative orientation of these regular secondary structure elements 
has nearly identical counterparts in the bovine pancreatic trypsin inhibitor (BPTI). In contrast, the loop between the/?-sheet and the C-terminal cc-helix 
as well as the N-terminal 20-residue segment preceding the /I-sheet adopt different three-dimensional folds in the two proteins. These observations 
are discussed with regard to the implication of different mechanisms of protease inhibition by rTAP and by Kunitz-type protein proteinase inhibitors. 
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1. Introduction 
A crucial step in blood coagulation is the conversion of 
prothrombin into its active form, thrombin. Efficient prote- 
olytic cleavage of prothrombin by factor Xa is achieved in a 
Ca2’-dependent assembly of prothrombin, factor Va and factor 
Xa on phospholipid membrane surfaces. Thrombin then con- 
verts fibrinogen into fibrin, which together with activated plate- 
lets forms clots that impede blood loss [ 1,2]. Regulation of the 
proteolytic enzymes of the coagulation cascade has long at- 
tracted much interest. Hirudin, a thrombin inhibitor from the 
leech Hirudo medicinalis [3], has been extensively studied and 
its structure has been solved in the free form by nuclear mag- 
netic resonance (NMR) spectroscopy [4-61 and in complexes 
with thrombin by X-ray crystallography [7,8]. Antistasin [9], 
ghilanten [lo], trypstatin [ll] and tick anticoagulant protein 
(TAP) [12] are inhibitors of factor Xa which have all been 
purified, but no three-dimensional structures have so far been 
determined. Here we report the NMR solution structure of 
recombinant TAP (rTAP) and compare this structure with that 
of Kunitz-type proteinase inhibitors. 
TAP was originally isolated from the soft tick Ornithodoros 
moubata. It is a highly selective inhibitor of factor Xa while 
exhibiting no inhibitory activity against other common serine 
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proteases uch as trypsin, chymotrypsin or thrombin [ 121. Anal- 
ysis of the reaction pathway of its inhibitory interaction with 
factor Xa [13] and site-directed mutagenesis tudies suggest a 
different mode of action from that of the common Kunitz-type 
proteinase inhibitors [14]. Knowledge of the three-dimensional 
structure of rTAP should help to obtain a better understanding 
of the inhibitory mechanism and to further evaluate possible 
therapeutic applications, all the more since the three-dimen- 
sional structure of a truncated form of factor Xa, which lacks 
the N-terminal 45 residues, has recently also been solved [15]. 
2. Materials and methods 
2.1. Protein preparation 
rTAP was expressed with the metallothionein (CUPI) inducible pro- 
moter in yeast on a IO-liter scale and purified from the extracellular 
medium [16]. Centrifuged medium was concentrated using cross-flow 
membranes (Herasette 14 cm x 14 cm, 3 kDa cutoff, Heraeus Instru- 
ments, Zurich). The concentrate was then batch adsorbed to Lichropep 
Reverse Phase C-18 silica (7 micron particle diameter) (Merck, Darm- 
stadt). Following filtration, the silica was washed sequentially with 
water and with 15% aqueous CH,CN containing 0.1% TFA. Active 
rTAP was eluted in batch mode with 50% aqueous CH,CN, 0.1% TFA. 
The eluate was diluted with buffer A (0.1% aqueous TFA) and loaded 
onto a preparative reverse phase Lichrosphere 100 RP C-18 column 
(50 x 250 mm, 7 micron particle diameter) on a Sep Tech Nova Prep 
HPLC. The column was washed with 28% of buffer B (80% aqueous 
CH, CN containing 0.08% TFA) using a flow rate of 80 mllmin, and 
rTAP was eluted with a linear gradient o 48% buffer B in 44 min. The 
CH,CN was removed by rotary evaporation, and the rTAP-containing 
fractions were pooled and lyophilized. The lyophilizate gave a slightly 
brown-colored solution in 8% CHJOOH, which was loaded onto a 
Sephacryl S-100 column (880 x 25 mm, Pharmacia, Uppsala) equili- 
brated with 5% CH,COOH at a flow rate of 1.4 ml/min in order to 
remove the colored contaminant. 
2.2. NMR spectroscopy 
NMR spectra were obtained from 8 mM rTAP samples, either in a 
mixture of 90% H,O/lO% ‘H,O. or in 99.99% 2H,0 after comnlete 
exchange of all labik protons. The protein samples were adjusted to pH 
3.6 by the addition of minute amounts of NaOH and HCI, or NaO’H 
and ‘HCI, respectively. The spectra were recorded on Bruker AMX 500 
and AMX 600 spectrometers and the temperature of all experiments 
used for the structure determination was 36.0 f 0S”C. In order to 
assign the proton resonances, homonuclear ZQF-COSY [17], clean- 
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TOCSY [18] and NOESY [19] (mixing time r, = 100 ms) spectra were 
recorded in both H,O and ‘H,O solution, and 3QF-COSY [20] and 
2Q-spectra [21] were recorded in *H,O. 
The conformational constraints for the structure determination of 
rTAP were collected from the following 600 MHz spectra: NOE upper 
bounds on ‘H-‘H distances were obtained from two NOESY experi- 
ments with t, = 50 ms and selective suppression of zero-quantum co- 
herences [22]. A data set in H,O solution was recorded with 
1,024 x 4,096 complex points, with t, ~,~ = 76 ms and t, my1 = 303 ms. 
A data set in 2H,0 used 650 x 4,096 complex points, with t, max = 53 ms 
and 
TOCSY [18] spectra at 36°C immediately after the lyophilized 
protein was dissolved in *H,O at p2H 3.6. The acquisition time of each 
individual spectrum was 1.5 h. 
2.3. Collection of conformational constraints and determination of the 
three-dimensional structure 
We followed the procedure outlined in [26] for the input collection 
and the structure calculation, using the programs XEASY (C. Bartels, 
T.X. Xia, P. Giintert, M. Billeter and K. Wiithrich, to be published), 
INFIT [23], CALIBA [27], HABAS [28], GLOMSA [271, DIANA 
[27,29] and ASNO [30]. Several rounds of structure calculations with 
DIANA and NOESY cross peak assignments with ASNO were per- 
formed. No hydrogen bond constraints were included in the input for 
DIANA. Disulfide bonds, as determined by chemical methods [31] were 
constrained in the same way as described in [32]. The final round of 
DIANA structure calculations was started with 50 randomized con- 
formers and included two REDAC cycles [29]. The resulting 20 DIANA 
conformers with the smallest residual target function values were sub- 
jected to restrained energy minimization using the AMBER force field 
[33] as implemented in the program OPAL (P. Luginbtihl, P. Giintert, 
M. Billeter and K. Wtithrich, to be published). These 20 energy-refined 
conformers were used to represent he solution structure of rTAP. 
3. Results 
3.1. Protein characterization 
Purified rTAP was homogeneous by electrophoresis on 
17.25% cross-linking acrylamide gels. Analytical reverse-phase 
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Fig. 1. (a) CD spectra of rTAP at different temperatures: dashed line 
10°C solid line 36°C dotted-dashed line 80°C. (b) Plot of the ellipticity 
at 223 nm vs. temperature. 
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Fig. 2. Contour plot of the spectral region (w, = O-9.2 ppm, o, = 6.4 
9.2 ppm) of a 600 MHz NOESY spectrum of rTAP (protein concentra- 
tion 8 mM, solvent 90% H,O/lO% ‘H,O, pH = 3.6, T = 36°C r, = 50 
ms). The dNN assignment pathway for the a-helical segment 53 to 59 
is represented by vertical and horizontal lines connecting consecutive 
sequential cross peaks (encircled). The arrows below the diagonal indi- 
cate the start and the end of the pathway. The amide proton chemical 
shift positions of residues 53 to 59 are indicated on the left. 
chromatography (Lichrosphere 100, 5 micron, endcapped, 
125 x 4 mm, Merck, Darmstadt) showed rTAP eluting as a 
single peak at 25.4 min using a gradient from 20 to 43% of 
buffer B in 50 min with a flow rate of 1.6 mllmin. The mass was 
determined on a PE Sciex API III triple quadrupole mass spec- 
trometer using electrospray ionization, and yielded a value of 
6,978.l (mean of three independent measurements), which is in 
excellent agreement with the value of 6,978.0 determined from 
the amino acid composition. Coincidence of the amino acid 
sequence with that of natural TAP was confirmed by N-termi- 
nal amino acid analysis performed on an Applied Biosystems 
470A protein sequencer and PTH-amino acid identification 
from HPLC elution against derivatized amino acid standards 
[34]. The activity of purified rTAP was determined by its capac- 
ity to prolong clotting times on an ACL 300R coagulometer 
using human plasma, and it was shown to double the APTT 
(activated partial thromboplastin time) and the PT (throm- 
boplastin time) at 1.9pM and 4.2,uM, respectively. In addition, 
it was shown to inhibit the activity of bovine factor Xa (Sigma, 
St. Louis) with a K, value of 16 nM, using the factor Xa sub- 
strate Chromozym X (Boehringer Mannheim) [35]. 
Circular dichroism (CD) spectra of rTAP were recorded on 
a JASCO J-710 spectropolarimeter in 20 mM sodium phos- 
phate at pH 3.6. Increase of the negative ellipticity near 220 nm 
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Fig. 3. Plot vs. the amino acid sequence of the number, n, and types of 
NOE constraints per residue used in the calculation of the solution 
structure of rTAP. The following code is used to define the different 
ranges of the NOE constraints: black, intraresidual; cross-hatched, 
sequential; vertically hatched, medium-range; white, long-range. 
upon heating of the sample indicates secondary structure 
changes (Fig. la) with a broad reversible transition centered 
around 55°C (Fig. lb). Based on the denaturation curve in Fig. 
lb we attempted to work at the lowest possible temperature. 
However, at temperatures of 25’C or below, rTAP in aqueous 
solution at pH 3.6 gave very broad ‘H NMR lines, probably 
because of self-aggregation. In the pH range 4.g5.5 the protein 
precipitated, and at pH 6.5 we obtained only poor quality ‘H 
NMR spectra. Therefore we eventually decided to proceed with 
the structure determination at pH 3.6 and 36 “C. Fig. 2 illus- 
trates that ‘H NMR spectra of good quality were obtained 
under these conditions, which are representative of a folded, 
globular protein. 
3.2. ‘H NMR assignments 
Sequence-specific ‘H NMR assignments for rTAP were ob- 
tained using standard methods for small proteins [36], with 
computer support utilizing the program XEASY. As an illus- 
tration, Fig. 2 shows the sequential assignments for residues 
53-59 in the C-terminal a-helix. The complete chemical shift list 
for the backbone amide protons and all non-labile hydrogen 
atoms is presented in the Appendix, which also includes assign- 
ments for numerous labile side chain protons. 
3.3. Survey of conformational constraints and structure 
calculation 
803 NOE cross peaks were unambiguously assigned and inte- 
grated. 658 NOE distance constraints resulted after elimination 
of the irrelevant constraints (Fig. 3). Coupling constants ‘JHN, 
were obtained for 47 residues, and values of ‘J, were obtained 
for 42 residues. The intraresidual and sequential NOE distance 
constraints combined with the -‘JHNa and ‘JM coupling con- 
stants yielded a total of 142 dmedral angle constraints (52 for 
@, 52 for v, and 38 for x’) when analyzed with the program 
HABAS. Individual assignments were obtained for 13 pairs of 
diastereotopic substituents (see the Appendix), using the pro- 
grams HABAS and GLOMSA. An overview of the results of 
the structure calculation after energy minimization of the 
DIANA conformers is provided in Table 1. 
3.4. The three-dimensional structure of rTAP 
The polypeptide backbone fold of rTAP is shown in Fig. 4. 
The elements of regular secondary structure in rTAP consist of 
a twisted two-stranded antiparallel b-sheet with residues 22-28 
and 32-38, and an a-helix comprising residues 51-60. The pol- 
ypeptide segments 1-3, 8-10, 18-20 and 29-30 are less well 
defined than the rest of the polypeptide backbone, and they also 
have low density of NOE distance constraints (Fig. 3). The 
average of the pairwise global RMSD values relative to the 
mean structure calculated for the backbone atoms N, C” and 
C’ of residues 47, ll-17,21-28 and 31-60 is 0.96 A (Table 2); 
when including also the side chains of the 23 residues with the 
‘best-defined’ side chains (those for which the side chain dis- 
placements after global backbone superposition are smaller 
than 2.0 A, see Table 2 and Fig. 5) the RMSD value increases 
only slightly to 1.00 A. The side chains of Trp”, Phez6, Phe36, 
Ile3’, Tyr48 and Tyr49 exhibit an outstandingly large number of 
long-range NOES (Fig. 3), and a close inspection of the three- 
dimensional structure reveals that these residues are the princi- 
pal components of the hydrophobic core of rTAP 
The exchange of backbone amide protons with the solvent 
is rather fast. After 5 h in ‘HZ0 at 36°C and p2H 3.6, all labile 
protons in the protein were completely replaced by deuterions. 
Fig. 6 shows that the residues with slowed amide proton ex- 
change are all located in polypeptide segments for which the 
spatial structure is well defined by the NMR data (Table 2). 
They are mostly amide protons that form the characteristic 
hydrogen bonds in the regular secondary structure elements, 
namely Ala24, Phez6, Asp 34 Phe36 and Ile38 in the p-sheet, and , 
Cy?, Phe56, Asr?‘, Alas8 CYSTS and Ile6’ in the a-helix. These 
regular hydrogen bonds are highly populated among the 20 
conformers that represent he NMR structure (Table 3). Resi- 
due Tyr*‘, which has a slowly exchanging amide proton, is 
related by NOES with the slowly exchanging amide proton of 
Tyr49, showing that Tyr*’ forms a one-residue, third antiparallel 
B-strand, which is a feature that was previously also reported 
for BPTI [26,37]. 
rTAP contains 11 side chain carboxylates in addition to the 
C-terminus, whereas positive charges are located on the 
N-terminus, 7 Arg and Lys, and one His. It is thus an acidic 
protein with an isoelectric point of about 4.5. The B-sheet in- 
Table 1 
Analysis of the 20 DIANA conformers of rTAP with the lowest residual 
target function values 
Quantity Average value f SD.” 
Target function (A’) 8.6 f 3.1 
AMBER energy (kcal/mol) - 1646? 84 
NOE constraint violations: 
sum (A) 14.3 f 1.0 
maximum (A) 0.2 + 0.0 
Dihedral angle constraint violations: 
number > 5” 1.2 f 1.6 
sum (deg) 53.0 + 12.6 
maximum (deg) 5.4 + 0.8 
“Average values and standard deviations are listed for the group of 20 
conformers. In the structure calculations the weighting factors for the 
NOE upper distance constraints were 1, for the van der Waals lower 
distance limits 2, and for dihedral angle constraints 5 A*. The target 
function value is given for the 20 DIANA conformers before energy 
minimization, all other data are for the same group of conformers after 
energy-refinement with the program OPAL. 
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eludes 2 positively and 2 negatively charged side chains, the 
a-helix one of each, but the large majority of the charged 
groups are observed in the loop regions outside of the regular 
secondary structures (Fig. 6). In the global three-dimensional 
structure there is a pronounced asymmetric harge distribution. 
In the standard orientation (Figs. 4 and 5) the negatively 
charged groups are crowded in the upper half of the molecule 
(residues 10-19 and 4147), and there is a clear-cut surplus of 
positive charges in the lower half (residues l-9,30, 53) (Fig. 7). 
The residues Asp , ” Th? Se?‘, Ala5*, CYSTS and IleW exhibit , 
strong dNN sequential NOE connectivities and have at the same 
time large values of the ‘JHN, coupling constant. In particular 
for the C-terminal tripeptide segment 58860, for which the 
patterns of sequential and medium-range NOE connectivities 
suggest hat these residues belong to the a-helix, the observa- 
tion of 3JHN, values larger than 7.0 Hz was unexpected. These 
apparent inconsistencies [36] may manifest increased local mo- 
bility of the protein under the experimental conditions used (see 
Fig. 1). 
The atomic coordinates of the 20 energy-minimized DIANA 
conformers used to represent he solution structure of rTAP 
have been deposited in the Brookhaven data bank, together 
with the complete input of conformational constraints used for 
the structure calculation. 
4. Discussion 
The rTAP sequence includes features that are reminiscent of 
some sequence properties of the large family of Kunitz-type 
protein proteinase inhibitors. These proteins, and particularly 
BPTI, have been the subject of detailed conformational studies 
by X-ray crystallography [37-391 as well as NMR [26,40,41]. A 
sequence alignment of the five members of this protein family 
for which a three-dimensional structure is available, i.e. BPTI 
[26], Toxin K [41], a-DTX [39], APPI [38] and ShPI [40], shows 
identical spacing of the cysteinyl residues, and a detailed struc- 
ture comparison revealed only minor conformational differ- 
ences [40], indicating that the protease inhibitory activities of 
BPTI, APPI and ShPI rely probably on identical inhibitory 
mechanisms. In this section we attempt o gain further insight 
into possible structure-function correlations in rTAP by com- 
parison with BPTI. 
Although the disulfide bond pattern of rTAP, S-59, 15-39 
and 33-55 [31], resembles that of the Kunitz-type inhibitors, no 
18 18 
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Fig. 4. Stereo view of the polypeptide backbone of the 20 final, energy- 
refined DIANA conformers used to represent the NMR structure of 
rTAP in solution. The backbone atoms N, C” and C’ of the residues 
47, 1 I-17, 21-28 and 31-60 of the conformers 1 to 20 were superim- 
posed for minimal RMSD with the mean structure (Table 2). Some 
C” positions are identified with the sequence numbers. 
Fig. 5. Stereo view of an all-heavy-atom representation of one of the 
energy-refined conformers of rTAP in the same orientation as in Fig. 
4. The polypeptide backbone atoms N, C” and C’ are connected with 
a thick line. Best-defined side chains as listed in Table 2 are drawn with 
medium lines, the other side chains with thin lines. The locations of the 
chain-terminal residues 1 and 60 are also indicated. 
significant level of sequence homology could be detected (Fig. 
6). The three-dimensional structures of BPTI and rTAP show 
good superposition of the regular secondary structure elements 
and the dipeptide segment preceding the a-helix (Fig. 8) which 
contains the corresponding residues Phe45 in BPTI and Tyr49 
in rTAP. The side chains of these two residues are similarly 
oriented relative to other molecular regions in the two proteins, 
and show similar patterns of long-range NOES to both the 
a-helix and the /?-sheet. Outside of these regions the fold of 
rTAP differs considerably from that of the common Kunitz- 
type protease inhibitors. The close fit of the regular secondary 
structure elements (Fig. 8) along with insertions and deletions 
of polypeptide segments immediately before and after the 
p-sheet enforces large structural differences. In BPTI, the sec- 
ond strand of the B-sheet extends up to residue 35, and it is 
followed by the tripeptide segment Gly-Gly-Cys in an extended 
conformation, with Cys3* forming a disulfide bridge with Cys14, 
which is the residue preceding the active site. A sequence align- 
ment of all the proteins which are classified as BPTI/Kunitz- 
Table 2 
RMSD values calculated for different atom selections in the solution 
structure of rTAP 
Atoms used for comparison” RMSD 
(A, f S.D.b 
bb (l-60) 
bb (4-7, ll-17,21-28, 31-60) 
Same + best-defined side chains’ 
All heavy atoms (4-7, 11-17, 21-28, 31-60) 
bb (20-28, 32-38, 51-60)” 
bb rTAP mean (22-28, 32-38, 51-60) with 
1.37 f 0.22 
0.96 f 0.17 
1.00 f 0.17 
1.48 ?r 0.20 
0.60 f 0.10 
bb BPTI mean (18-24, 29935, 47-56)d 0.99 
“bb stands for the backbone heavy atoms N, C” and C’. The numbers 
in parentheses indicate the residues for which the RMSD was calcu- 
lated. 
bAverages are given of the pairwise RMSD values between each of the 
20 energy-refined DIANA conformers and the mean solution structure. 
RSMD values were calculated with the program XAM [44]. 
‘Best-defined side chains are those with global displacements smaller 
than 2.0 A and include the following 23 residues: 5, 11, 15, 2426, 35, 
36, 3840, 43, 44, 49952, 5456, 58860. 
dThese residues form the antiparallel B-sheet and the cc-helix. For the 
comparison of rTAP with BPTI the mean coordinates of the NMR 
structures of the two proteins were used, and the superposition is for 
the best fit of the p-sheet and the u-helix. 
Fig. 6. Tentative partial alignment of the amino acid sequences of rTAP 
and BPTI based on the assumption that the cysteinyl residues are in 
corresponding positions. Sequence identities are indicated by shaded 
boxes. Larger boxes indicate regions with near-identity of the three- 
dimensional structure (see Fig. 8). Outside of these large boxes, paren- 
theses indicate segments for which no satisfactory alignment could be 
obtained either using sequence arguments or three-dimensional struc- 
ture arguments. Arrows indicate the disulfide bond pairings. The regu- 
lar secondary structure elements are indicated above and below the 
respective sequencesTriangles above the rTAP sequence indicate resi- 
dues with observably slow amide proton exchange at36‘C and pH 3.6 
(see text). 
type proteinase inhibitor homologs in the SwissProt sequence 
database shows that the residue preceding Cys in the above 
tripeptide segment is a strictly conserved glycine. Furthermore, 
the local backbone conformation of this residue in the three- 
dimensional structure of BPTI can only be satisfied by a 
glycine. In rTAP the second B-sheet extends up to residue 38, 
and the residues corresponding to Gly36 and Gly37 in BPTI are 
Table 3 
Backbonebackbone hydrogen bonds identified in the solution struc- 
ture of rTAP 
Donor” AcceptoP Conformersb 
14 Glu NH 12 Ile 0 13 
19 Glu NH 17 Ser 0 II 
24 Ala NH 36 Phe 0 18 
25 Tyr NH 49 Tyr 0 12 
26 Phe NH 34 Asp 0 12 
27 Arg NH 5 cys 0 19 
28 Asn NH 32 Gly 0 11 
30 Lys NH 28 Asn 0 10 
34 Asp NH 26 Phe 0 18 
38 Ile NH 22 Glu 0 14 
55 cys NH 51 Ser 0 14 
56 Phe NH 52 Tyr 0 20 
57 Asn NH 53 Arg 0 20 
58 Ala NH 54 Asp 0 19 
59 cys NH 55 cys 0 18 
60 Be NH 56 Phe 0 20 
“NH and 0’ stand for the backbone amide protons and carbonyl oxy- 
gens. Residues with slowly exchanging amide protons at p*H 3.6 and 
36°C are indicated in bold face. 
% each individual conformer a hydrogen bond is identified if the 
proton-acceptor distance is less than 2.4 A, and the angle between the 
donor-proton bond and the line connecting the donor and acceptor 
atoms is less than 35”. Hydrogen bonds are reported if this criterion 
is met in at least 10 of the 20 energy-refined DIANA conformers of 
rTAP. This column lists the number of conformers that fulfil the above 
criteria. 
missing. As a result, Cys3’, which forms a disulfide bond with 
CYs Is, is situated immediately after the second strand of the 
/?-sheet (Fig. 6). This enforces different locations of this disul- 
fide bond in the two molecules, and the conformations of the 
two loops that are connected by this disulfide bond are widely 
different in the two proteins (Fig. 8). 
Overall the picture emerging is that of an amazingly faithful 
conservation of a structural scaffold between rTAP and the 
Kunitz-type inhibitors, which consists of the p-sheet and the 
cc-helix (Fig. 8). This scaffold supports distinctly different con- 
necting loop regions, which are presumably responsible for 
conferring different functional properties to the two types of 
molecules. 
In earlier work [ 141 it was found that a mutation of AspI in 
rTAP to Arg or Lys, which corresponds to conservation of the 
residue type in the corresponding position of BPTI, does not 
result in a rTAP mutant with inhibitory activity against trypsin. 
In view of the different loop structures carrying this residue 
position in the two proteins (Fig. 8) and also considering the 
crowding with negative charges of the rTAP region correspond- 
ing to the active site in BPTI (Fig. 7) this result can readily be 
rationalized on the basis of the three-dimensional structure. 
Similarly, previous site-directed mutagenesis tudies indicated 
two regions of rTAP that contribute to the high-affinity bind- 
ing interaction with factor Xa. The first comprises the three 
N-terminal residues and constitutes the primary binding deter- 
minant [14]. This N-terminal tripeptide shows only few NOE 
distance constraints (Fig. 3), appears to be flexibly disordered 
and probably adopts a defined conformation only upon bind- 
ing to the enzyme. A region between residues 40 and 54 consti- 
tutes a probable secondary binding determinant [14]. The pres- 
ently described three-dimensional structure shows clearly that 
neither of these two binding regions are located near the posi- 
tion corresponding to the protease-binding site in BPTI, impli- 
cating distinctly different inhibitory mechanisms for rTAP and 
BPTI. 
Despite the similarity of the secondary structure elements of 
rTAP and BPTI, the amide proton exchange in rTAP is many 
orders of magnitude faster than in BPTI [42]. Past experience 
with a variety of Kunitz-type inhibitors [43] implies that the 
R9 
R53 
Fig. 7. Ribbon drawing of rTAP showing the locations of charged 
groups. Same orientation as in Fig. 4. The backbone is represented by 
a thin line. Arg or Lys side chains, and Asp or Glu side chains, respec- 
tively, are represented by open and filled ball and stick drawings, and 
the individual residues are identified with the one-letter amino acid 
symbols and the sequence locations. The two chain ends are indicated 
with encircled numbers. 
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Fig. 8. Superposition of ribbon drawings of the rTAP and BPTI mean 
NMR structures generated with the program MOLSCRIPT [45] after 
fit for minimal RMSD of the residues corresponding to positions 22-28, 
32-38 and 51-60 in rTAP (Table 2). Dark gray shading corresponds to 
BPTI, and rTAP is white. The disulfide bonds are represented by ball 
and stick drawings. 
extent of this difference cannot simply be related to the differ- 
ence in thermal stability of the two proteins. Furthermore, in 
contrast to BPTI, all the aromatic ring undergo rapid flipping 
motions about the @-C? bond (Table Al), which indicates 
increased internal mobility [36]. It remains to be seen whether 
these features are yet another structural determinant of the 
implicated different modes of action of the two classes of inhib- 
itors. 
With regard to the so far rather elusive inhibitory mechanism 
of rTAP, further studies are planed in collaboration with the 
group of Prof. R. Huber, MPI Martinsried, to investigate pos- 
sible contact sites by molecular modeling using the present 
rTAP structure and the crystal structure of factor Xa [ 151. 
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Appendix 
Table Al 
‘H NMR chemical shifts of rTAP in aqueous solution at pH 3.6 and T = 36°C 
Residue Chemical shift (ppm)* 
NH aH BH Others 
Tyr 1 
Asn 2 
Arg 3 
Leu 4 
cys 5 
Ile 6 
Lys 1 
Pro 8 
Arg 9 
Asp 10 
Trp 11 
Ile 12 
Asp 13 
Glu 14 
cys 15 
Asp 16 
Ser 17 
Asn 18 
Glu 19 
Gly 20 
Gly 21 
Glu 22 
Arg 23 
Ala 24 
Tyr 25 
Phe 26 
Arg 21 
Asn 28 
Gly 29 
Lys 30 
Gly 31 
Gly 32 
cys 33 
Asp 34 
Ser 35 
Phe 36 
Trp 37 
Ile 38 
cys 39 
Pro 40 
Glu 41 
Asp 42 
His 43 
Thr 44 
Gly 45 
Ala 46 
Asp 41 
Tyr 48 
Tyr 49 
Ser 50 
Ser 51 
Tyr 52 
Arg 53 
Asp 54 
cys 55 
Phe 56 
Asn 51 
Ala 58 
cys 59 
Ile 60 
8.42 
8.40 
8.20 
8.18 
1.43 
8.23 
8.32 
8.13 
1.32 
7.90 
8.55 
7.19 
7.94 
8.13 
7.90 
8.03 
1.11 
7.88 
1.94 
8.23 
8.19 
8.60 
7.88 
8.39 
9.05 
8.38 
8.53 
8.43 
8.28 
7.91 
7.30 
9.15 
8.14 
8.78 
8.30 
8.56 
8.32 
8.56 
1.15 
1.11 
8.12 
8.45 
7.70 
8.06 
1.26 
9.91 
9.16 
7.31 
8.15 
8.35 
7.31 
6.89 
8.97 
8.06 
7.10 
8.19 
7.11 
4.24 
4.67 
4.09 
4.33 
4.85 
4.33 
2.22 
4.04 
3.85 
4.55 
4.41 
4.21 
4.89 
4.64 
4.15 
4.19 
3.90 
4.52 
4.29 
3.81, 3.99 
3.89, 4.17 
4.51 
4.28 
4.86 
5.11 
4.99 
4.64 
4.91 
3.94, 4.01 
4.58 
3.61, 4.26 
3.94, 4.56 
5.60 
5.13 
4.51 
4.52 
4.70 
4.29 
4.91 
4.08 
4.06 
4.49 
4.70 
4.34 
3.17, 4.01 
4.23 
4.60 
4.36 
4.55 
4.92 
4.33 
2.85 
3.73 
4.23 
3.16 
3.50 
4.29 
4.32 
4.82 
3.90 
3.11, 3.11 
2.11, 2.92 
1.40, 1.49 
1.42, 1.75 
2.87, 3.08 
1 .I2 
0.34, 0.96 
1.24, 2.08 
1.70, 1.70 
2.13, 2.85 
2.81, 2.94 
1.65 
2.83, 2.88 
2.00, 1.86 
3.04, 2.99 
2.60, 2.65 
3.59, 3.45 
2.70 
2.12, 1.83 
6H 7.05, 7.05; EH 6.75, 6.75 
6NH, 6.93, 7.54 
yCH, 1.41; KHz 2.80, 2.88; .sNH 6.99 
yH 1.64, 6CH, 0.66, 0.71 
yCH, 1.40, 1.10; yCH, 0.71; 6CH, 0.75 
yCH, -0.12, 0.60; KHz 0.52, 0.60; ECH, 2.10, 2.21 
yCH, 1.58; KHz 2.04, 3.22 
yCH, 1.58; JCH, 3.11; &NH 7.08 
6’H 6.86; E’H 7.08; E’NH 9.92; PH 7.31; 13H 6.80; $H 6.75 
yCH, 1.29, 1.11; yCH, 0.81; JCH, 0.75 
yCH, 2.13, 2.31 
6NH, 6.71, 1.42 
yCH, 2.32 
1.88, 2.06 
0.87, 1.15 
0.88 
2.25, 2.40 
3.29 2.45, 
1.76, 1.76 
3.21, 2.62 
yCH, 2.36 
yCH, 0.69, 0.78; SCH, 2.62, 2.70; &NH 6.76; vNH, 6.40 
SH 6.54, 6.54; EH 6.66, 6.66 
6H 6.82, 6.82; EH 6.63, 6.63; & 6.27 
yCH, 1.56; 6CH, 2.96; &NH 7.14 
6NH2 7.14, 7.66 
1.48, 1.95 yCHz 1.24; EH, 1.60; ECH, 2.92 
3.21, 2.14 
2.64, 2.68 
2.88, 2.88 
2.69, 3.16 
2.87, 3.28 
1.67 
2.54, 3.25 
1.87, 2.25 
1.77, 1.99 
2.33, 2.13 
3.14, 3.23 
4.31 
6H 7.20, 7.20; EH 7.26, 7.26; m 7.17 
6’H 7.19; F’H 7.32; .s’NH 9.89; CH 7.36; C’H 6.90; $H 7.13 
yCH, 0.95, 1.55; yCH, 0.68; SCH9 0.55 
yCH, 1.97, 2.08; 6CH2 3.72, 3.79 
yCH, 2.35 
S2H 7.14; E’H 8.40 
yCH, 1.20 
1.12 
2.61, 2.49 
3.13, 2.58 
2.15, 3.06 
4.25, 3.93 
3.81, 3.16 
2.55, 2.64 
1.60, 1.82 
2.50, 2.67 
2.14, 2.61 
2.38, 2.16 
2.69, 2.14 
1.22 
2.87, 2.87 
1.47 
6H 7.11, 7.11; EH 6.83, 6.83 
6H 7.08, 7.08; EH 6.50, 6.50 
SH 6.82, 6.82; EH 6.17, 6.11 
yCHz 1.52; JCH, 3.11; &NH 7.08 
SH 6.95, 6.95; EH 7.38, 7.38; @I 7.29 
SNH, 6.67, 7.58 
yCH, 0.82, 1.00; yCHl 0.58; 6CH, 0.43 
*The chemical shifts are in ppm relative to internal sodium [2,2,3,3-2H,]-3-trimethylsilylpropionate. For methylene groups two chemical shifts are 
given only when two separate resonance lines were observed or the presence of two degenerate resonances was evidenced by 24 spectroscopy. 
Individual assignments for pairs of diastereotopic substituents obtained using the programs HABAS and GLOMSA are indicated by underlined 
chemical shift values. The chemical shift of the proton with the lower branch number is listed first, e.g. the /I’ proton. 
